Peter D. Zang

Oncology | Hematology Oncology

1500 Duarte Rd
Duarte, CA 91010

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Real-World Efficacy and Safety of Belzutifan in Sporadic Metastatic Renal Cell Carcinoma.

Real-World Efficacy and Safety of Belzutifan in Sporadic Metastatic Renal Cell Carcinoma.

Journal: Clinical genitourinary cancer

Published: April 22, 2026

Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial Availability.

Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial Availability.

Journal: Cancers

Published: April 12, 2026

Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors.

Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors.

Journal: Cancer research communications

Published: March 31, 2026

CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.

CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.

Journal: Journal for immunotherapy of cancer

Published: March 13, 2026

Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Journal: Therapeutic advances in medical oncology

Published: September 08, 2025

Immunotherapy in Renal Cell Carcinoma.

Immunotherapy in Renal Cell Carcinoma.

Journal: Cancer treatment and research

Published: August 23, 2025

BRCA To the Future: Platinum Chemotherapy in Biomarker-Selected Metastatic Castrate Resistant Prostate Cancer.

BRCA To the Future: Platinum Chemotherapy in Biomarker-Selected Metastatic Castrate Resistant Prostate Cancer.

Journal: JCO precision oncology

Published: August 07, 2025

Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.

Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.

Journal: Frontiers in oncology

Published: July 19, 2025

Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung Carcinoma.

Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung Carcinoma.

Journal: JCO precision oncology

Published: April 10, 2025

Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer.

Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer.

Journal: Cancers

Published: March 29, 2025

IDO Believe in Immunotherapy.

IDO Believe in Immunotherapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 06, 2025

CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and Beyond.

CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and Beyond.

Journal: Annual review of medicine

Published: November 21, 2024

Showing 1-12 of 22

Last Updated: 09/26/2026